Skip to main content
Bruce Gillis, MD, Internal Medicine, Los Angeles, CA, Cedars-Sinai Medical Center

BruceSGillisMD

Internal Medicine Los Angeles, CA

Adult Clinical & Laboratory Immunology, Preventive Medicine, Occupational Medicine

Physician

Dr. Gillis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Gillis' full profile

Already have an account?

Summary

  • I developed what is currently the first and only university medical center developed, award-winning, objective, peer-reviewed and published and FDA-compliant blood test for diagnosing fibromyalgia, an immune system disorder that is the result of the effects of dysfunctional peripheral blood mononuclear cells and their inability to produce normal quantities of particular chemokines and cytokines. We will soon commence a clinical vaccine trial at the Massachusetts General Hospital to reverse the biology of fibromyalgia.

Education & Training

  • Los Angeles County-Harbor-UCLA Medical Center
    Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1975 - 1977
  • Harvard School of Public Health Occupational Medicine
    Harvard School of Public Health Occupational MedicineResidency, Preventive Medicine, 1973 - 1974
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1974

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1980 - 2026
  • HI State Medical License
    HI State Medical License 1983 - 2026
  • CA State Medical License
    CA State Medical License 1975 - 2025

Publications & Presentations

PubMed

Press Mentions

  • Pathway to Prevent / Improve the Treatment of Deadly COVID-19 Infections Revealed in EpicGenetics-Funded Study of Thousands of Fibromyalgia Patients
    Pathway to Prevent / Improve the Treatment of Deadly COVID-19 Infections Revealed in EpicGenetics-Funded Study of Thousands of Fibromyalgia PatientsApril 21st, 2021
  • 7 Fibromyalgia Experts Discuss the Covid-19 Vaccine
    7 Fibromyalgia Experts Discuss the Covid-19 VaccineFebruary 22nd, 2021
  • University of Illinois College of Medicine and EpicGenetics Deploy Test to Determine Patients Most Likely to Avoid Potentially Fatal Cytokine Storms That May Trigger the Most Severe Cases of COVID-19
    University of Illinois College of Medicine and EpicGenetics Deploy Test to Determine Patients Most Likely to Avoid Potentially Fatal Cytokine Storms That May Trigger the Most Severe Cases of COVID-19June 11th, 2020
  • Join now to see all

Hospital Affiliations